Skip to main content

Table 1 Characteristics of all patients with viral retinitis

From: Socioeconomic disadvantage and impact on visual outcomes in patients with viral retinitis and retinal detachment

Case Age (y)/ Sex National ADI ADI group Insurance type Missed appointments Bilateral retinitis Bilateral RD Cause of immune dysfunction Causative virus Zonal classification Area of viral retinitis (DAs) Type of primary surgery Tamponade
1 59/F 3 Low No insurance 1 Yes No N/A HSV 2, 3  > 34 PPV Silicone oil
2 42/F 6 Low Private 0 No No N/A HSV 3 4 PPV/SB SF6
3 65/M 11 Low Medicare 0 No No Chronic Lymphocytic Leukemia HSV 2, 3 12 PPV/SB Silicone oil
4 50/F 15 Low Private 0 Yes No Transplantation, Myelodysplastic syndrome CMV 3 N/A PPV SF6
5 29/M 22 Low Public 0 No No HIV CMV 1, 2, 3 22 PPV Silicone oil
6 39/M 24 Low Public 2 Yes Yes HIV CMV 2, 3 18 PPV/SB Silicone oil
7 59/M 26 Low Private 3 Yes No HIV CMV 3 6 PPV SF6
8 69/F 27 Low Medicare 3 No No Non-Hodgkin’s Lymphoma CMV 3 6 PPV/SB C3F8
9 82/M 28 Low Private 0 No No Steroids, Sarcoidosis CMV 3 4 PPV SF6
10 37/F 33 Low Private 0 No No HIV CMV 2, 3 22 SB N/A
11 52/F 34 Low Private 0 Yes Yes Steroids HSV 3  > 30 PPV/SB Silicone oil
12 50/M 34 Low Private 1 Yes Yes N/A VZV 3 34 PPV/SB SF6
13 44/F 43 High Medicare 1 Yes Yes HIV CMV 2 12 PPV Silicone oil
14 36/F 50 High Medicare 14 Yes Yes HIV CMV 3 8 PPV/SB SF6
15 40/F 58 High Public 12 Yes No HIV CMV 1, 2, 3  > 30 PPV Silicone oil
16 44/F 77 High Public 13 Yes No HIV CMV 3  > 34 PPV/SB Silicone oil
17 32/F 91 High Public 10 No No N/A CMV 2 4 PPV Silicone oil
18 32/F 99 High Medicare 10 Yes Yes HIV VZV 3 N/A PPV/SB Silicone oil
  1. ADI Area Deprivation Index, HIV human immunodeficiency virus, SLE systemic lupus erythematosus, CMV cytomegalovirus, HSV herpes simplex virus, VZV varicella zoster virus, DAs disc areas, PPV pars plana vitrectomy, SB scleral buckle, PPV/SB pars plana vitrectomy with scleral buckle, SF6 sulfur hexafluoride, C3F8 perfluoropropane